Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical

For many, getting older can unfortunately mean an increased risk of illness from cardiovascular disease to cancer. University of Michigan scientists are actively researching the biological underpinnings of aging with the aim of developing interventions that could potentially help people live longer, healthier lives.

A new paper in the journal Science Advances describes the discovery of several promising small molecules that appear to reduce in mouse skin and could lengthen life.

“Cellular resistance appears to be a common feature of long-lived organisms, such as invertebrates and mice,” says the paper’s lead author David Lombard, M.D., Ph.D., associate professor of pathology. Lombard is part of a multidisciplinary group at U-M’s Paul F. Glenn Center for Aging. Recent research from colleague and fellow study author Richard Miller, M.D., Ph.D., found several promising drugs, including rapamycin, a cancer drug, and acarbose, a diabetes drug, that extended life in mice.

Read more | >

Summary: A patient who suffered brain injury can temporarily walk, talk, and recognize family members thanks to the sleep medication Zolpidem.

Source: Radboud University

A patient who could not move and talk spontaneously for eight years started to do so again after being administered a sleeping pill. The spectacular but temporary effect was visualized with brain scans, giving researchers from Radboud university medical center and Amsterdam UMC a better understanding of this disorder’s underlying neurophysiological processes. The article has been published in Cortex.

Read more | >

On a blustery winter day last December, a car carrying radioactive material approached one of the Port Authority of New York and New Jersey’s major transportation hubs. As the car got closer, an alarm flashed and sounded on a large monitor in the police operations center, identifying on a digital map the exact location of the vehicle and the specific radioactive isotope radiating from the car – Cesium-137. Within minutes, officers in the Port Authority Police Department – equipped with vehicle-mounted and pocket-sized radiation sensors displaying the same real-time digital map – tracked the vehicle and apprehended the suspects in a parking lot. Thankfully, the potential terrorists and radiation-emitting isotope were not a threat, as the scenario was only a drill.

The December exercise marked the capstone for DARPA’s SIGMA program, culminating a five-year effort to develop and deploy an automated, high-performance, networked radiation detection capability for counterterrorism and continuous city-to-region scale radiological and nuclear threat monitoring. The transition of the radiation-detection system took place prior to the coronavirus disease (COVID-19) pandemic. In the eight months since the SIGMA transition, DARPA has been developing and testing additional sensors under its SIGMA+ effort to detect chemical, biological and explosive threats as well.

“We want to thank the Port Authority for their outstanding support throughout the SIGMA program and their continued support as we test SIGMA+ sensors,” said Mark Wrobel, DARPA program manager in the Defense Sciences Office. “Being able to test and refine the system in the country’s largest metropolitan region was invaluable in taking SIGMA from a research project to an operationally deployed system in just five years.”

Read more | >

An experimental new vaccine claims to be able to change human DNA and could be deployed against COVID-19 by 2021 through a biochip implant.

The most significant scientific discovery since gravity has been hiding in plain sight for nearly a decade and its destructive potential to humanity is so enormous that the biggest war machine on the planet immediately deployed its vast resources to possess and control it, financing its research and development through agencies like the National Institutes of Health (NIH), the Defense Advanced Research Projects Agency (DARPA) and HHS’ BARDA.

The revolutionary breakthrough came to a Canadian scientist named Derek Rossi in 2010 purely by accident. The now-retired Harvard professor claimed in an interview with the National Post that he found a way to “reprogram” the molecules that carry the genetic instructions for cell development in the human body, not to mention all biological lifeforms.

These molecules are called ‘messenger ribonucleic acid’ or mRNA and the newfound ability to rewrite those instructions to produce any kind of cell within a biological organism has radically changed the course of Western medicine and science, even if no one has really noticed yet. As Rossi, himself, puts it: “The real important discovery here was you could now use mRNA, and if you got it into the cells, then you could get the mRNA to express any protein in the cells, and this was the big thing.”

Read more | >

Researchers at the National Institute of Standards and Technology (NIST) have developed a new method of 3D-printing gels and other soft materials. Published in a new paper, it has the potential to create complex structures with nanometer-scale precision. Because many gels are compatible with living cells, the new method could jump-start the production of soft tiny medical devices such as drug delivery systems or flexible electrodes that can be inserted into the human body.

A standard 3D printer makes solid structures by creating sheets of material — typically plastic or rubber — and building them up layer by layer, like a lasagna, until the entire object is created.

Using a 3D printer to fabricate an object made of gel is a “bit more of a delicate cooking process,” said NIST researcher Andrei Kolmakov. In the standard method, the 3D printer chamber is filled with a soup of long-chain polymers — long groups of molecules bonded together — dissolved in water. Then “spices” are added — special molecules that are sensitive to light. When light from the 3D printer activates those special molecules, they stitch together the chains of polymers so that they form a fluffy weblike structure. This scaffolding, still surrounded by liquid water, is the gel.

Read more | >

TODAY (Oct 4th) the USTP is holding a special pre-RAADFest Enlightenment Salon at 7 a.m. PST / 10 am EST with Gabor Kiss, CEO of ENVIENTA, to discuss ways to empower contributors to open-source projects and accelerate development of practical transhumanist technologies.

Ira Pastor, ideaXme life sciences ambassador, interviews Dr. Alexandre Kalache, President of the International Longevity Centre-Brazil (ILC-Brazil).

Ira Pastor Comments:

As we continue our virtual road-trip around the globe per the World Health Organization’s (WHO) Age Friendly Cities Global Movement, during the WHO defined “Decade of Healthy Aging”, we are headed down to the southern hemisphere to the country of Brazil.

Dr. Alexandre Kalache:

Dr. Alexandre Kalache is a medical epidemiologist specializing in the study of aging, who is the President of the International Longevity Centre-Brazil (ILC-Brazil), an independent think tank based in Rio de Janeiro that develops and promotes policy related to population aging, and Co-President of the Global Alliance of International Longevity Centres, an international consortium of member organizations with a mission to help societies to address longevity and population aging in positive and productive ways.

Dr. Kalache graduated from the medical school of the Federal University of Rio de Janeiro, gained diplomas in infectious and parasitic diseases and medical education, was awarded a master’s degree in Social Medicine from the London School of Hygiene and Tropical Medicine, his PhD in Epidemi ology at the University of London, and had a long academic career at the Universities of London and Oxford in the United Kingdom.

Dr. Kalache’s work in Aging:

Read more | >

In the coming 2020s, the world of medical science will make some significant breakthroughs. Through brain implants, we will have the capability to restore lost memories.

~ The 2020s will provide us with the computer power to make the first complete human brain simulation. Exponential growth in computation and data will make it possible to form accurate models of every part of the human brain and its 100 billion neurons.

~ The prototype of the human heart was 3D printed in 2019. By the mid- 2020s, customized 3D- printing of major human body organs will become possible. In the coming decades, more and more of the 78 organs in the human body will become printable.

…As we enter into the next few decades, we will have the technologies that grant us the possibility of immortality, albeit one that is highly subjective.

With our ability to 3D print new body organs, our ability to use nanotechnology in fighting death at cellular levels, our ability to use CRISPR or other gene-editing technology to rewrite our definition of humans and even our ability to capture and extend our consciousness beyond the confines of the biological weakness of our human bodies — immortality may be within reach of our fingers as depicted in the painting of Michelangelo.

The race to human 2.0 will be run broadly in two spectrums — the evolution of our body and the evolution of our minds.

Excerpt from my book — 2020s & The Future Beyond.

#Future #Humanity #Transhumanism

Read more | >